Importantly, immunohistochemical analysis revealed that ESCC tissue with higher expression levels of cytoplasmic PURα had a lower expression of IGFBP3, supporting that PURα inhibits the mRNA translation of IGFBP3 [55]. The gene discussed is PURA; the disease is esophageal squamous cell carcinoma.